Correction: The Anti-CD19 Antibody–Drug Conjugate SAR3419 Prevents Hematolymphoid Relapse Postinduction Therapy in Preclinical Models of Pediatric Acute Lymphoblastic Leukemia

In this article (Clin Cancer Res 2013;19:1795–805), which was published in the April 1, 2013, issue of Clinical Cancer Research (1), the clinical trial identifier NCT01440197 is incorrect. The correct study number is NCT01440179.

The online version has been corrected and no longer matches the print version. The authors regret this error.